AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...
Following HSBC downgrading of the semiconductor company's stock, Advanced Micro Devices ( AMD, Financials) shares fell over 5 ...
The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...
Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial ...
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...
Investing.com -- Shares of Absci Corporation (NASDAQ: ABSI) soared 50% following the announcement of a strategic ...
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, today announced a strategic collaboration ...
Analyst Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on AbSci (ABSI – Research Report) and keeping the price target at ...
EST Cathie Wood’s ARK Investment buys 609K shares of Absci (ABSI) todayStay Ahead of the Market:Discover outperforming stocks and invest ...
AMD's technology will also be used to boost Absci's drug discovery workload, including the company's de novo antibody design ...
Absci (ABSI) was rising after a media report on a $20M investment by the semiconductor company Advanced Micro Devices (AMD) in the AI drug creation company.
Absci Corp (ABSI) stock saw a modest uptick, ending the day at $3.22 which represents a slight increase of $0.15 or 4.89% from the prior close of $3.07. The stock opened at $4.09 and touched a low of ...